Get startedLog in
    Picture of China Medical System Holdings logo

    867 — China Medical System Holdings News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Brief: China Medical System Says Approval By Nmpa To Conduct Phase 3 Clinical Trial For Ruxolitinib Cream

    Picture of China Medical System Holdings logoChina Medical System Holdings
    12/12/2023 15:44
    Dec 12 (Reuters) - China Medical System Holdings Ltd
 0867.HK :
    * APPROVAL BY NMPA OF CHINA TO CONDUCT A PHASE 3 CLINICAL
TRIAL
INVESTIGATING RUXOLITINIB CREAM IN VITILIGO IN CHINA


Further company coverage:  0867.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on China Medical System Holdings

    See all news